Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company is headquartered in Omer, Israel.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-10.33M |
| Operating Margin | 0.00% |
| Return on Equity | -17.60% |
| Return on Assets | -6.24% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.78 |
| Price-to-Sales (TTM) | 1.59 |
| EV/Revenue | 0.0161 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 578.00% |
| Shares Outstanding | $6.50M |
| Float | $2.09M |
| % Insiders | 43.40% |
| % Institutions | 0.00% |
Volatility is currently expanding